Trials / Completed
CompletedNCT01814670
Treatment With Botulinum Toxin Type A (BOTOX®) in Chinese Patients With Moderate to Severe Frown Lines
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 185 (actual)
- Sponsor
- Allergan · Industry
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
A study to evaluate safety and efficacy of treatment with botulinum toxin Type A (BOTOX®) in Chinese patients with moderate to severe frown lines (Glabellar Rhytides) previously treated with facial laser resurfacing.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | botulinum toxin Type A | 20 units botulinum toxin Type A (total dose) injected into frown lines on Day 1. |
Timeline
- Start date
- 2013-03-06
- Primary completion
- 2014-07-31
- Completion
- 2014-10-29
- First posted
- 2013-03-20
- Last updated
- 2019-04-17
- Results posted
- 2015-09-01
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT01814670. Inclusion in this directory is not an endorsement.